News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
503,061 Results
Type
Article (52718)
Company Profile (338)
Press Release (450005)
Multimedia
Podcasts (65)
Webinars (12)
Section
Business (138864)
Career Advice (1316)
Deals (21444)
Drug Delivery (65)
Drug Development (69055)
Employer Resources (99)
FDA (10068)
Job Trends (10286)
News (238407)
Policy (18730)
Tag
Academia (2642)
Academic (1)
Accelerated approval (5)
Adcomms (16)
Allergies (71)
Alliances (38801)
ALS (86)
Alzheimer's disease (1342)
Antibody-drug conjugate (ADC) (124)
Approvals (10082)
Artificial intelligence (219)
Autoimmune disease (23)
Automation (9)
Bankruptcy (157)
Best Places to Work (8313)
BIOSECURE Act (13)
Biosimilars (52)
Biotechnology (263)
Bladder cancer (69)
Brain cancer (25)
Breast cancer (248)
Cancer (2059)
Cardiovascular disease (151)
Career advice (1100)
Career pathing (21)
CAR-T (147)
Cell therapy (412)
Cervical cancer (15)
Clinical research (55244)
Collaboration (799)
Compensation (307)
Complete response letters (16)
COVID-19 (2155)
CRISPR (47)
C-suite (215)
Cystic fibrosis (100)
Data (2116)
Decentralized trials (2)
Denatured (20)
Depression (47)
Diabetes (208)
Diagnostics (4113)
Digital health (11)
Diversity (4)
Diversity, equity & inclusion (26)
Drug discovery (116)
Drug pricing (64)
Drug shortages (9)
Duchenne muscular dystrophy (98)
Earnings (52007)
Editorial (31)
Employer branding (15)
Employer resources (87)
Events (74380)
Executive appointments (610)
FDA (11158)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (687)
Gene editing (112)
Generative AI (18)
Gene therapy (312)
GLP-1 (574)
Government (2613)
Grass and pollen (3)
Guidances (127)
Healthcare (12919)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (110)
Indications (25)
Infectious disease (2269)
Inflammatory bowel disease (136)
Inflation Reduction Act (9)
Influenza (43)
Intellectual property (84)
Interviews (262)
IPO (10868)
IRA (31)
Job creations (2385)
Job search strategy (948)
Kidney cancer (7)
Labor market (29)
Layoffs (359)
Leadership (10)
Legal (3153)
Liver cancer (50)
Lung cancer (284)
Lymphoma (132)
Machine learning (7)
Management (30)
Manufacturing (231)
MASH (68)
Medical device (6908)
Medtech (6911)
Mergers & acquisitions (11059)
Metabolic disorders (541)
Multiple sclerosis (73)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (27)
Neuroscience (1861)
NextGen: Class of 2025 (4078)
Non-profit (3653)
Now hiring (31)
Obesity (259)
Opinion (181)
Ovarian cancer (76)
Pain (68)
Pancreatic cancer (75)
Parkinson's disease (138)
Partnered (17)
Patents (177)
Patient recruitment (101)
Peanut (43)
People (41771)
Pharmaceutical (59)
Pharmacy benefit managers (9)
Phase I (18091)
Phase II (24565)
Phase III (17449)
Pipeline (1226)
Policy (106)
Postmarket research (2096)
Preclinical (8613)
Press Release (68)
Prostate cancer (91)
Psychedelics (38)
Radiopharmaceuticals (234)
Rare diseases (362)
Real estate (4105)
Recruiting (37)
Regulatory (14604)
Reports (30)
Research institute (2546)
Resumes & cover letters (187)
Rett syndrome (5)
RNA editing (5)
RSV (27)
Schizophrenia (71)
Series A (123)
Series B (77)
Service/supplier (10)
Sickle cell disease (53)
Special edition (19)
Spinal muscular atrophy (138)
Sponsored (23)
Startups (2816)
State (1)
Stomach cancer (5)
Supply chain (42)
Tariffs (26)
The Weekly (44)
Vaccines (551)
Venture capitalists (36)
Weight loss (156)
Women's health (26)
Worklife (10)
Date
Last 7 days (780)
Last 30 days (2400)
Last 365 days (26434)
2025 (9454)
2024 (28586)
2023 (32289)
2022 (42392)
2021 (44944)
2020 (40550)
2019 (32040)
2018 (23895)
2017 (24069)
2016 (23403)
2015 (28032)
2014 (21616)
2013 (18426)
2012 (18249)
2011 (18702)
2010 (17654)
Location
Africa (582)
Alabama (55)
Alaska (4)
Arizona (113)
Arkansas (6)
Asia (30952)
Australia (5686)
California (5188)
Canada (1646)
China (479)
Colorado (209)
Connecticut (238)
Delaware (136)
Europe (71052)
Florida (704)
Georgia (173)
Idaho (31)
Illinois (376)
India (24)
Indiana (218)
Iowa (8)
Japan (149)
Kansas (86)
Kentucky (13)
Louisiana (5)
Maine (20)
Maryland (723)
Massachusetts (4036)
Michigan (170)
Minnesota (260)
Mississippi (1)
Missouri (52)
Montana (22)
Nebraska (11)
Nevada (34)
New Hampshire (33)
New Jersey (1509)
New Mexico (26)
New York (1496)
North Carolina (808)
North Dakota (7)
Northern California (2278)
Ohio (171)
Oklahoma (11)
Oregon (28)
Pennsylvania (1052)
Puerto Rico (7)
Rhode Island (23)
South America (670)
South Carolina (15)
Southern California (2003)
Tennessee (56)
Texas (721)
United States (19061)
Utah (115)
Virginia (121)
Washington D.C. (52)
Washington State (504)
West Virginia (1)
Wisconsin (40)
503,061 Results for "lambda therapeutic research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Lisata Therapeutics Announces Research License with Catalent
April 15, 2025
·
7 min read
Press Releases
Ono Commences Research Collaboration with Jorna Therapeutics to Generate Novel RNA Editing Therapeutics
April 21, 2025
·
3 min read
Sebia Receives U.S. FDA Clearance for the FLC Kappa & Lambda Assays
Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the FLC Kappa & Lambda assays.
February 29, 2024
·
2 min read
Press Releases
ViVerita Therapeutics Announces Research Collaboration with Boehringer Ingelheim to Accelerate Discovery of Novel Cancer Targets
May 7, 2025
·
2 min read
Press Releases
Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025
April 24, 2025
·
4 min read
Press Releases
Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health
May 9, 2025
·
8 min read
Press Releases
Obsidian Therapeutics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
April 25, 2025
·
3 min read
Press Releases
ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025
April 28, 2025
·
6 min read
Press Releases
Lirum Therapeutics Invited to Present at Prestigious Gordon Research Conference
March 19, 2025
·
3 min read
1 of 50,307
Next
